US Patent Issued to Tolremo Therapeutics on June 9 for "Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of fibrotic disease" (Swiss Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,947, issued on June 9, was assigned to Tolremo Therapeutics AG (Muttenz, Switzerland).

"Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of fibrotic disease" was invented by Stefanie Fluckiger-Mangual (Muttenz, Switzerland) and Thomas Bohnacker (Muttenz, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compound of formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, cocrystal, tautomer, racemate, enantiomer, or diastereomer or mixture thereof and to pharmaceutical compositions comprising a compound of formula (I)...